{"transactions":[{"id":671914,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T10:05:03.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":1.5581,"value":3116.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $1.5581. The range of sale prices on the transaction date was $1.55 to $1.5619 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-26-011121","document":"marketforms-73912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926011121/marketforms-73912.xml","form_type":"4"}},{"id":671913,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T10:00:20.000Z","date":"2026-04-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.0338,"value":2067.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.0338. The range of purchase prices on the transaction date was $1.00 to $1.05 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001214659-26-011111","document":"marketforms-73911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926011111/marketforms-73911.xml","form_type":"4/A","original_submission_date":"2026-04-16"}},{"id":671912,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T10:00:20.000Z","date":"2026-04-14","kind":"purchase","planned":false,"acquired":true,"shares":108388,"price":1.0047,"value":108897.4236,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":116648,"source":{"system":"sec-edgar","filing":"0001214659-26-011111","document":"marketforms-73911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926011111/marketforms-73911.xml","form_type":"4/A","original_submission_date":"2026-04-16"}},{"id":671911,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T10:00:18.000Z","date":"2026-04-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.0338,"value":2067.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.0338. The range of purchase prices on the transaction date was $1.00 to $1.05 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001214659-26-011110","document":"marketforms-73911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926011110/marketforms-73911.xml","form_type":"4/A","original_submission_date":"2026-04-16"}},{"id":671910,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T10:00:18.000Z","date":"2026-04-14","kind":"purchase","planned":false,"acquired":true,"shares":108388,"price":1.0047,"value":108897.4236,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":116648,"source":{"system":"sec-edgar","filing":"0001214659-26-011110","document":"marketforms-73911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926011110/marketforms-73911.xml","form_type":"4/A","original_submission_date":"2026-04-16"}},{"id":680548,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":717,"kind":"organization","name":"Hyperscale Data, Inc.","symbol":"GPUS","position":1,"cik":"0000896493","reported_name":"Hyperscale Data, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by deputization"}},{"id":21392,"kind":"person","name":"Ault Lending, LLC","position":2,"cik":"0002149572","reported_name":"Ault Lending, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by deputization"}},{"id":21393,"kind":"person","name":"Ault Capital Group, Inc.","position":3,"cik":"0002074623","reported_name":"Ault Capital Group, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by deputization"}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-08-21T01:18:24.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":1000,"value":7500000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock has a stated value of $ 1,050.00 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.2668 and (ii) 80% of the lowest closing bid price of the Common Stock during the five (5) trading days immediately prior to the date of conversion into conversion shares, but not greater than $2.00 per share (the \"Conversion Price\"). The Conversion Price is subject to adjustment in the event of issuances of Common Stock at a price per share lower than the Conversion Price then in effect, as well as upon customary stock splits, stock dividends, combinations or similar events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series D Convertible Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"As of August 4, 2026, the Conversion Price was $1,016 per share, so each share of Series D Convertible Preferred Stock is convertible into approximately 1,033.5 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Ault Lending LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Capital Group, Inc. (\"ACG\"). ACG is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":7500,"derivative":{"exercise_date":"2026-07-31","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-26-010677","document":"marketforms-73837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896493/000121465926010677/marketforms-73837.xml","form_type":"4/A","original_submission_date":"2026-08-04"}},{"id":698002,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":717,"kind":"organization","name":"Hyperscale Data, Inc.","symbol":"GPUS","position":1,"cik":"0000896493","reported_name":"Hyperscale Data, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by deputization"}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-08-05T01:38:33.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":1000,"value":7500000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock has a stated value of $1,050.00 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.2668 and (ii) 80% of the lowest closing bid price of the Common Stock during the five (5) trading days immediately prior to the date of conversion into conversion shares, but not greater than $2.00 per share (the \"Conversion Price\"). The Conversion Price is subject to adjustment in the event of issuances of Common Stock at a price per share lower than the Conversion Price then in effect, as well as upon customary stock splits, stock dividends, combinations or similar events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series D Convertible Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"As of August 4, 2026, the Conversion Price was $1.016 per share, so each share of Series D Convertible Preferred Stock is convertible into approximately 1,033.5 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Capital Group, Inc. (\"ACG\"). ACG is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":7500,"derivative":{"exercise_date":"2026-07-31","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-26-009596","document":"marketforms-73681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/896493/000121465926009596/marketforms-73681.xml","form_type":"4"}},{"id":696990,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-08-05T01:35:49.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":1000,"value":7500000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock has a stated value of $1,050.00 and is convertible into shares of Common Stock at a conversion price equal to the greater of (i) $0.2668 and (ii) 80% of the lowest closing bid price of the Common Stock during the five (5) trading days immediately prior to the date of conversion into conversion shares, but not greater than $2.00 per share (the \"Conversion Price\"). The Conversion Price is subject to adjustment in the event of issuances of Common Stock at a price per share lower than the Conversion Price then in effect, as well as upon customary stock splits, stock dividends, combinations or similar events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series D Convertible Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"As of August 4, 2026, the Conversion Price was $1.016 per share, so each share of Series D Convertible Preferred Stock is convertible into approximately 1,033.5 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Capital Group, Inc. (\"ACG\"). ACG is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":7500,"derivative":{"exercise_date":"2026-07-31","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-26-009594","document":"marketforms-73679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926009594/marketforms-73679.xml","form_type":"4"}},{"id":697251,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26668,"kind":"person","name":"Nisser Henry Carl","position":1,"cik":"0001775938","reported_name":"Nisser Henry Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:25.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Nisser to purchase 60,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":60000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-009591","document":"marketforms-73669.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1775938/000121465926009591/marketforms-73669.xml","form_type":"5"}},{"id":696991,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:24.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Ault to purchase 100,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":100000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-26-009590","document":"marketforms-73668.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926009590/marketforms-73668.xml","form_type":"5"}},{"id":696984,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:20.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Horne to purchase 60,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":60000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-009589","document":"marketforms-73672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465926009589/marketforms-73672.xml","form_type":"5"}},{"id":697349,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26690,"kind":"person","name":"Oram Jeffrey","position":1,"cik":"0001864444","reported_name":"Oram Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:19.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Oram to purchase 60,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":60000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-009588","document":"marketforms-73667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864444/000121465926009588/marketforms-73667.xml","form_type":"5"}},{"id":697059,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:17.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Gustafson to purchase 60,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":60000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-009587","document":"marketforms-73671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465926009587/marketforms-73671.xml","form_type":"5"}},{"id":697348,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26689,"kind":"person","name":"Jackman Stephan","position":1,"cik":"0001864257","reported_name":"Jackman Stephan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:16.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Jackman to purchase 450,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":450000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001214659-26-009586","document":"marketforms-73673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864257/000121465926009586/marketforms-73673.xml","form_type":"5"}},{"id":697351,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26692,"kind":"person","name":"Katzoff David J","position":1,"cik":"0001864317","reported_name":"Katzoff David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:14.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Katzoff to purchase 300,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":300000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001214659-26-009585","document":"marketforms-73674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864317/000121465926009585/marketforms-73674.xml","form_type":"5"}},{"id":806894,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:30:09.000Z","date":"2026-04-14","kind":"purchase","planned":false,"acquired":true,"shares":108388,"price":1.0047,"value":108897.4236,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":116648,"source":{"system":"sec-edgar","filing":"0001214659-26-004742","document":"marketforms-72943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465926004742/marketforms-72943.xml","form_type":"4"}},{"id":957062,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-30T22:54:03.000Z","date":"2025-12-23","kind":"sale","planned":false,"acquired":false,"shares":1851,"price":2.0665,"value":3825.0915,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such shares were sold at the direction of the reporting person, for purposes of realizing tax losses."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-25-018631","document":"marketforms-71713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925018631/marketforms-71713.xml","form_type":"4"}},{"id":959430,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:30:14.000Z","date":"2025-12-19","kind":"sale","planned":false,"acquired":false,"shares":3333,"price":2.1178,"value":7058.6274,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-25-018437","document":"marketforms-71665.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465925018437/marketforms-71665.xml","form_type":"4"}},{"id":1013874,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T16:30:08.000Z","date":"2025-10-23","kind":"sale","planned":false,"acquired":false,"shares":30,"price":2.29,"value":68.7,"ownership":{"direct":true},"balance_after":25,"source":{"system":"sec-edgar","filing":"0001214659-25-015288","document":"marketforms-71141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465925015288/marketforms-71141.xml","form_type":"4"}},{"id":1019997,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-10-10T20:30:13.000Z","date":"2025-10-08","kind":"exercise","planned":false,"acquired":false,"shares":143.2447,"price":1000,"value":143244.7,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":0,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-014861","document":"marketforms-71022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014861/marketforms-71022.xml","form_type":"4"}},{"id":1019996,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:30:13.000Z","date":"2025-10-09","kind":"sale","planned":false,"acquired":false,"shares":20397,"price":2.3234,"value":47390.3898,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":8260,"source":{"system":"sec-edgar","filing":"0001214659-25-014861","document":"marketforms-71022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014861/marketforms-71022.xml","form_type":"4"}},{"id":1019995,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:30:13.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":101394,"price":2.4376,"value":247158.0144,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.4376. The range of sales prices on the transaction date was $2.42 to $2.4634 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":28657,"source":{"system":"sec-edgar","filing":"0001214659-25-014861","document":"marketforms-71022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014861/marketforms-71022.xml","form_type":"4"}},{"id":1019994,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:30:13.000Z","date":"2025-10-08","kind":"exercise","planned":false,"acquired":true,"shares":61743,"price":2.32,"value":143243.76,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":130591,"source":{"system":"sec-edgar","filing":"0001214659-25-014861","document":"marketforms-71022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014861/marketforms-71022.xml","form_type":"4"}},{"id":1021348,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-10-08T10:50:55.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":143.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-014752","document":"marketforms-71017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014752/marketforms-71017.xml","form_type":"4"}},{"id":1021347,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-10-08T10:50:55.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":375.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-014752","document":"marketforms-71017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014752/marketforms-71017.xml","form_type":"4"}},{"id":1021346,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T10:50:55.000Z","date":"2025-10-07","kind":"sale","planned":false,"acquired":false,"shares":57379,"price":2.4914,"value":142954.0406,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.4914. The range of sales prices on the transaction date was $2.4381 to $2.4941 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":68848,"source":{"system":"sec-edgar","filing":"0001214659-25-014752","document":"marketforms-71017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014752/marketforms-71017.xml","form_type":"4"}},{"id":1021345,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T10:50:55.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":126227,"source":{"system":"sec-edgar","filing":"0001214659-25-014752","document":"marketforms-71017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014752/marketforms-71017.xml","form_type":"4"}},{"id":1021344,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T10:50:55.000Z","date":"2025-10-06","kind":"sale","planned":false,"acquired":false,"shares":82033,"price":2.4535,"value":201267.9655,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.4535. The range of sales prices on the transaction date was $2.4097 to $2.4599 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":26227,"source":{"system":"sec-edgar","filing":"0001214659-25-014752","document":"marketforms-71017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014752/marketforms-71017.xml","form_type":"4"}},{"id":1021343,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T10:50:55.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":108260,"source":{"system":"sec-edgar","filing":"0001214659-25-014752","document":"marketforms-71017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014752/marketforms-71017.xml","form_type":"4"}},{"id":1024286,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-10-04T01:35:01.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":607.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-014629","document":"marketforms-70943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014629/marketforms-70943.xml","form_type":"4"}},{"id":1024285,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T01:35:01.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":65903,"price":2.4413,"value":160888.9939,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.4413. The range of sales prices on the transaction date was $2.4409 to $2.467 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":8260,"source":{"system":"sec-edgar","filing":"0001214659-25-014629","document":"marketforms-70943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014629/marketforms-70943.xml","form_type":"4"}},{"id":1024284,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T01:35:01.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":20686,"price":2.394,"value":49522.284,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":74163,"source":{"system":"sec-edgar","filing":"0001214659-25-014629","document":"marketforms-70943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014629/marketforms-70943.xml","form_type":"4"}},{"id":1024283,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T01:35:01.000Z","date":"2025-10-01","kind":"sale","planned":false,"acquired":false,"shares":36777,"price":2.3487,"value":86378.1399,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.3487. The range of sales prices on the transaction date was $2.317 to $2.4038 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":94849,"source":{"system":"sec-edgar","filing":"0001214659-25-014629","document":"marketforms-70943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014629/marketforms-70943.xml","form_type":"4"}},{"id":1024282,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T01:35:01.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":131626,"source":{"system":"sec-edgar","filing":"0001214659-25-014629","document":"marketforms-70943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014629/marketforms-70943.xml","form_type":"4"}},{"id":1030403,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T23:15:07.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":3566,"price":2.3334,"value":8320.9044,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":31626,"source":{"system":"sec-edgar","filing":"0001214659-25-014420","document":"marketforms-70885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014420/marketforms-70885.xml","form_type":"4"}},{"id":1030402,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T23:15:07.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":38324,"price":2.309,"value":88490.116,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":35192,"source":{"system":"sec-edgar","filing":"0001214659-25-014420","document":"marketforms-70885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014420/marketforms-70885.xml","form_type":"4"}},{"id":1030401,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T23:15:07.000Z","date":"2025-09-26","kind":"sale","planned":false,"acquired":false,"shares":37738,"price":2.3145,"value":87344.601,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":73516,"source":{"system":"sec-edgar","filing":"0001214659-25-014420","document":"marketforms-70885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014420/marketforms-70885.xml","form_type":"4"}},{"id":1032173,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-09-26T00:59:14.000Z","date":"2025-09-25","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":839.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-014210","document":"marketforms-70866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014210/marketforms-70866.xml","form_type":"4"}},{"id":1032172,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-26T00:59:14.000Z","date":"2025-09-25","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":111254,"source":{"system":"sec-edgar","filing":"0001214659-25-014210","document":"marketforms-70866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014210/marketforms-70866.xml","form_type":"4"}},{"id":1032171,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-26T00:59:14.000Z","date":"2025-09-25","kind":"sale","planned":false,"acquired":false,"shares":14628,"price":2.3126,"value":33828.7128,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11254,"source":{"system":"sec-edgar","filing":"0001214659-25-014210","document":"marketforms-70866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014210/marketforms-70866.xml","form_type":"4"}},{"id":1032170,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-26T00:59:14.000Z","date":"2025-09-24","kind":"sale","planned":false,"acquired":false,"shares":39140,"price":2.309,"value":90374.26,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.3090. The range of sales prices on the transaction date was $2.3088 to $2.3217 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":25882,"source":{"system":"sec-edgar","filing":"0001214659-25-014210","document":"marketforms-70866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014210/marketforms-70866.xml","form_type":"4"}},{"id":1032169,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-26T00:59:14.000Z","date":"2025-09-23","kind":"sale","planned":false,"acquired":false,"shares":43238,"price":2.3757,"value":102720.5166,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":65022,"source":{"system":"sec-edgar","filing":"0001214659-25-014210","document":"marketforms-70866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014210/marketforms-70866.xml","form_type":"4"}},{"id":1033649,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-09-23T20:30:08.000Z","date":"2025-09-22","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":1071.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-014056","document":"marketforms-70836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014056/marketforms-70836.xml","form_type":"4"}},{"id":1033648,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:30:08.000Z","date":"2025-09-22","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":108260,"source":{"system":"sec-edgar","filing":"0001214659-25-014056","document":"marketforms-70836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014056/marketforms-70836.xml","form_type":"4"}},{"id":1033647,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:30:08.000Z","date":"2025-09-19","kind":"sale","planned":false,"acquired":false,"shares":77009,"price":2.3485,"value":180855.6365,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":8260,"source":{"system":"sec-edgar","filing":"0001214659-25-014056","document":"marketforms-70836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925014056/marketforms-70836.xml","form_type":"4"}},{"id":1035482,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-09-19T20:50:09.000Z","date":"2025-09-17","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":1303.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-013976","document":"marketforms-70818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925013976/marketforms-70818.xml","form_type":"4"}},{"id":1035481,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T20:50:09.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":20870,"price":2.4673,"value":51492.551,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":85269,"source":{"system":"sec-edgar","filing":"0001214659-25-013976","document":"marketforms-70818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925013976/marketforms-70818.xml","form_type":"4"}},{"id":1035480,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T20:50:09.000Z","date":"2025-09-17","kind":"sale","planned":false,"acquired":false,"shares":2121,"price":2.4535,"value":5203.8735,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":106139,"source":{"system":"sec-edgar","filing":"0001214659-25-013976","document":"marketforms-70818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925013976/marketforms-70818.xml","form_type":"4"}},{"id":1035479,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T20:50:09.000Z","date":"2025-09-17","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":108260,"source":{"system":"sec-edgar","filing":"0001214659-25-013976","document":"marketforms-70818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925013976/marketforms-70818.xml","form_type":"4"}},{"id":1077426,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-08-01T20:30:19.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":1000,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":1535.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-25-011356","document":"marketforms-70181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925011356/marketforms-70181.xml","form_type":"4"}},{"id":1077425,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-01T20:30:19.000Z","date":"2025-07-31","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":2.2155,"value":221550.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.2155. The range of sales prices on the transaction date was $2.1628 to $2.2511 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":8260,"source":{"system":"sec-edgar","filing":"0001214659-25-011356","document":"marketforms-70181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925011356/marketforms-70181.xml","form_type":"4"}},{"id":1077424,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-01T20:30:19.000Z","date":"2025-07-30","kind":"sale","planned":false,"acquired":false,"shares":29449,"price":2.5122,"value":73981.7778,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.5122. The range of sales prices on the transaction date was $2.4047 to $2.6367 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":108260,"source":{"system":"sec-edgar","filing":"0001214659-25-011356","document":"marketforms-70181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925011356/marketforms-70181.xml","form_type":"4"}},{"id":1077423,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-01T20:30:19.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.32,"value":232000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":137709,"source":{"system":"sec-edgar","filing":"0001214659-25-011356","document":"marketforms-70181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925011356/marketforms-70181.xml","form_type":"4"}},{"id":1079681,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-29T20:55:17.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":8311,"price":2.6849,"value":22314.2039,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":37709,"source":{"system":"sec-edgar","filing":"0001214659-25-011043","document":"marketforms-70149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925011043/marketforms-70149.xml","form_type":"4"}},{"id":1079680,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-29T20:55:17.000Z","date":"2025-07-25","kind":"sale","planned":false,"acquired":false,"shares":36532,"price":2.8976,"value":105855.1232,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8976. The range of sales prices on the transaction date was $2.891 to $2.9129 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":46020,"source":{"system":"sec-edgar","filing":"0001214659-25-011043","document":"marketforms-70149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925011043/marketforms-70149.xml","form_type":"4"}},{"id":1081340,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-07-26T00:00:10.000Z","date":"2025-07-23","kind":"exercise","planned":false,"acquired":false,"shares":332.7553,"price":1000,"value":332755.3,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Series B Preferred have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":1767.2447,"derivative":{"exercise_price":2.32,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":143429},"source":{"system":"sec-edgar","filing":"0001214659-25-010933","document":"marketforms-70140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925010933/marketforms-70140.xml","form_type":"4"}},{"id":1081339,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-26T00:00:10.000Z","date":"2025-07-24","kind":"sale","planned":false,"acquired":false,"shares":9621,"price":2.9349,"value":28236.6729,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":82552,"source":{"system":"sec-edgar","filing":"0001214659-25-010933","document":"marketforms-70140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925010933/marketforms-70140.xml","form_type":"4"}},{"id":1081338,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-26T00:00:10.000Z","date":"2025-07-23","kind":"sale","planned":false,"acquired":false,"shares":59516,"price":2.9502,"value":175584.1032,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":92173,"source":{"system":"sec-edgar","filing":"0001214659-25-010933","document":"marketforms-70140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925010933/marketforms-70140.xml","form_type":"4"}},{"id":1081337,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-26T00:00:10.000Z","date":"2025-07-23","kind":"exercise","planned":false,"acquired":true,"shares":143429,"price":2.32,"value":332755.28,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon conversion of Series B convertible preferred stock (\"Series B Preferred\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":151689,"source":{"system":"sec-edgar","filing":"0001214659-25-010933","document":"marketforms-70140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925010933/marketforms-70140.xml","form_type":"4"}},{"id":1148959,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:00:07.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":11,"price":5.2801,"value":58.0811,"ownership":{"direct":true},"balance_after":1843,"source":{"system":"sec-edgar","filing":"0001214659-25-007625","document":"marketforms-69458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925007625/marketforms-69458.xml","form_type":"4"}},{"id":1148958,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:00:07.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":1213,"price":5.0604,"value":6138.2652,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.0604. The range of sales prices on the transaction date was $5.0461 to $5.237 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":8260,"source":{"system":"sec-edgar","filing":"0001214659-25-007625","document":"marketforms-69458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925007625/marketforms-69458.xml","form_type":"4"}},{"id":1189589,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-27T11:30:10.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":3334,"price":0.9854,"value":3285.3236,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001214659-25-004857","document":"marketforms-68983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465925004857/marketforms-68983.xml","form_type":"4"}},{"id":1192085,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-25T20:30:07.000Z","date":"2025-03-21","kind":"purchase","planned":false,"acquired":true,"shares":2905,"price":1.022,"value":2968.91,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":85273,"source":{"system":"sec-edgar","filing":"0001214659-25-004752","document":"marketforms-68948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925004752/marketforms-68948.xml","form_type":"4"}},{"id":1193630,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26692,"kind":"person","name":"Katzoff David J","position":1,"cik":"0001864317","reported_name":"Katzoff David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T11:30:07.000Z","date":"2025-03-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.0096,"value":5048.0,"ownership":{"direct":true},"balance_after":5540,"source":{"system":"sec-edgar","filing":"0001214659-25-004643","document":"marketforms-68905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864317/000121465925004643/marketforms-68905.xml","form_type":"4"}},{"id":1195495,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-20T20:30:07.000Z","date":"2025-03-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9783,"value":4891.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9783. The range of purchase prices on the transaction date was $0.974 to $0.9799 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":26666,"source":{"system":"sec-edgar","filing":"0001214659-25-004592","document":"marketforms-68882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465925004592/marketforms-68882.xml","form_type":"4"}},{"id":1196865,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-03-19T20:30:09.000Z","date":"2025-03-18","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options exercised in this transaction were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":0.06,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-25-004545","document":"marketforms-68781.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465925004545/marketforms-68781.xml","form_type":"4"}},{"id":1196864,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T20:30:09.000Z","date":"2025-03-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9703,"value":4851.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9703. The range of purchase prices on the transaction date was $0.9693 to $0.9742 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":21666,"source":{"system":"sec-edgar","filing":"0001214659-25-004545","document":"marketforms-68781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465925004545/marketforms-68781.xml","form_type":"4"}},{"id":1196863,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T20:30:09.000Z","date":"2025-03-18","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0.06,"value":600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options."}],"balance_after":16666,"source":{"system":"sec-edgar","filing":"0001214659-25-004545","document":"marketforms-68781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465925004545/marketforms-68781.xml","form_type":"4"}},{"id":1199164,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T23:12:26.000Z","date":"2025-03-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.962,"value":4810.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":82368,"source":{"system":"sec-edgar","filing":"0001214659-25-004521","document":"marketforms-68778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925004521/marketforms-68778.xml","form_type":"4"}},{"id":1205535,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T21:30:07.000Z","date":"2025-03-12","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":0.6842,"value":68.42,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.6842. The range of purchase prices on the transaction date was $0.6841 to $0.6842 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Hyperscale Data, Inc. (\"HSD\"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":77368,"source":{"system":"sec-edgar","filing":"0001214659-25-004400","document":"marketforms-68750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465925004400/marketforms-68750.xml","form_type":"4"}},{"id":1433470,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T22:01:00.000Z","date":"2024-08-06","kind":"purchase","planned":false,"acquired":true,"shares":75,"price":2.75,"value":206.25,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":77268,"source":{"system":"sec-edgar","filing":"0001214659-24-014768","document":"marketforms-66781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924014768/marketforms-66781.xml","form_type":"4"}},{"id":1444184,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T21:20:08.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":25,"price":3.7368,"value":93.42,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.7368. The range of purchase prices on the transaction date was $3.592 to $3.95 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":77193,"source":{"system":"sec-edgar","filing":"0001214659-24-013576","document":"marketforms-66702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924013576/marketforms-66702.xml","form_type":"4"}},{"id":1514461,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T16:30:15.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":666,"price":0.881,"value":586.746,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares were sold in an individual retirement account owned by Mrs. McGrath's spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-24-009438","document":"marketforms-65906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465924009438/marketforms-65906.xml","form_type":"5"}},{"id":1536781,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-24T00:00:15.000Z","date":"2024-04-19","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.6882,"value":688.2,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.6882. The range of purchase prices on the transaction date was $0.6819 to $0.6895 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":771699,"source":{"system":"sec-edgar","filing":"0001214659-24-007439","document":"marketforms-65613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924007439/marketforms-65613.xml","form_type":"4"}},{"id":1548965,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-03T21:00:20.000Z","date":"2024-04-01","kind":"purchase","planned":false,"acquired":true,"shares":334,"price":0.9109,"value":304.2406,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":770699,"source":{"system":"sec-edgar","filing":"0001214659-24-006037","document":"marketforms-65487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924006037/marketforms-65487.xml","form_type":"4"}},{"id":1556033,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:30:20.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.0635,"value":2127.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":770365,"source":{"system":"sec-edgar","filing":"0001214659-24-005796","document":"marketforms-65425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924005796/marketforms-65425.xml","form_type":"4"}},{"id":1558272,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2024-03-28T20:30:50.000Z","date":"2024-03-26","kind":"purchase","planned":false,"acquired":true,"shares":780000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These warrants were issued for no additional consideration in connection with the purchase of the Series B Convertible Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Issuer is restricted from issuing shares of common stock upon conversion of the Series B Convertible Preferred Stock and /or exercise of the warrants to the extent such issuances would result in an aggregate number of shares of common stock exceeding 1,322,951, which represents 19.99% of the total shares of common stock issued and outstanding as of January 31, 2024, the execution date of the purchase agreement pursuant to which the shares of Series B Convertible Preferred Stock and warrants are issued, in accordance with the rules and regulations of the Nasdaq Stock Market unless the Issuer first obtains stockholder approval, which has not yet been obtained."}],"balance_after":2000000,"derivative":{"exercise_price":1.2,"exercise_date":"2024-09-26","expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":780000},"source":{"system":"sec-edgar","filing":"0001214659-24-005472","document":"marketforms-65403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924005472/marketforms-65403.xml","form_type":"4"}},{"id":1558271,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-03-28T20:30:50.000Z","date":"2024-03-26","kind":"purchase","planned":false,"acquired":true,"shares":780,"price":1000,"value":780000.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of series B convertible preferred stock (the \"Series B Convertible Preferred Stock\") have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series B Convertible Preferred Stock has a stated value of $1,000 (the \"Stated Value\") and is convertible into a number of shares of common stock determined by dividing the Stated Value by the conversion price, which is currently $1.00."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Issuer is restricted from issuing shares of common stock upon conversion of the Series B Convertible Preferred Stock and /or exercise of the warrants to the extent such issuances would result in an aggregate number of shares of common stock exceeding 1,322,951, which represents 19.99% of the total shares of common stock issued and outstanding as of January 31, 2024, the execution date of the purchase agreement pursuant to which the shares of Series B Convertible Preferred Stock and warrants are issued, in accordance with the rules and regulations of the Nasdaq Stock Market unless the Issuer first obtains stockholder approval, which has not yet been obtained."}],"balance_after":2000,"derivative":{"exercise_price":1,"exercise_date":"2024-03-26","underlying":"Common Stock","underlying_shares":780000},"source":{"system":"sec-edgar","filing":"0001214659-24-005472","document":"marketforms-65403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924005472/marketforms-65403.xml","form_type":"4"}},{"id":1661215,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2024-02-02T21:30:30.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":false,"shares":1220000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Ault Life Sciences Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These warrants were issued for no additional consideration in connection with the purchase of the Series A Convertible Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":1220000,"derivative":{"exercise_price":1.2,"exercise_date":"2024-07-31","expiration_date":"2029-07-31","underlying":"Common Stock","underlying_shares":1220000},"source":{"system":"sec-edgar","filing":"0001214659-24-001775","document":"marketforms-64535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924001775/marketforms-64535.xml","form_type":"4"}},{"id":1661214,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-02-02T21:30:30.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":false,"shares":1220,"price":1000,"value":1220000.0,"ownership":{"direct":false,"nature":"By Ault Life Sciences Fund, LLC"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of series A convertible preferred stock (the \"Series A Convertible Preferred Stock\") have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series A Convertible Preferred Stock has a stated value of $1,000 (the \"Stated Value\") and is convertible into a number of shares of common stock determined by dividing the Stated Value by the conversion price, which is currently $1.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":1220,"derivative":{"exercise_price":1,"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":1220000},"source":{"system":"sec-edgar","filing":"0001214659-24-001775","document":"marketforms-64535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924001775/marketforms-64535.xml","form_type":"4"}},{"id":1670751,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2024-01-25T22:20:14.000Z","date":"2024-01-23","kind":"other","planned":false,"acquired":false,"shares":666666,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Ault Life Sciences Fund, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These warrants were returned to the Issuer as part of the Settlement Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Ault has sole voting and investment power with respect to the securities held of record by ALSF."}],"balance_after":0,"derivative":{"exercise_price":45,"exercise_date":"2019-04-30","expiration_date":"2024-04-29","underlying":"Common Stock","underlying_shares":666666},"source":{"system":"sec-edgar","filing":"0001214659-24-001199","document":"marketforms-64498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924001199/marketforms-64498.xml","form_type":"4"}},{"id":1670750,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T22:20:14.000Z","date":"2024-01-23","kind":"other","planned":false,"acquired":false,"shares":661168,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Ault Life Sciences Fund, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares, which were pledged as security for the repayment of a promissory note owed by Ault Life Sciences Fund, LLC (\"ALSF\"), were returned to the Issuer as part of a settlement agreement between the Issuer and ALSF (the \"Settlement Agreement\"), whereby the outstanding obligation, among other rights, were terminated."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares, which were pledged as security for the repayment of a promissory note owed by Ault Life Sciences Fund, LLC (\"ALSF\"), were returned to the Issuer as part of a settlement agreement between the Issuer and ALSF (the \"Settlement Agreement\"), whereby the outstanding obligation, among other rights, were terminated."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Ault has sole voting and investment power with respect to the securities held of record by ALSF."}],"balance_after":5498,"source":{"system":"sec-edgar","filing":"0001214659-24-001199","document":"marketforms-64498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924001199/marketforms-64498.xml","form_type":"4"}},{"id":1682491,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T21:30:17.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.0185,"value":5092.5,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 26,032 shares of common stock previously owned by, and received from, Ault Alpha LP (\"Ault Alpha\"), in connection with the liquidation of Ault Alpha on December 28, 2023. Those 26,032 shares were previously reported as beneficially owned by Mr. Ault as Ault Alpha also reported as an indirect beneficial ownership under Mr. Ault, so no change in beneficial ownership of those shares occurred in connection with the liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AAI\"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":768365,"source":{"system":"sec-edgar","filing":"0001214659-24-000495","document":"marketforms-64064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465924000495/marketforms-64064.xml","form_type":"4"}},{"id":1699388,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-27T21:30:16.000Z","date":"2023-12-26","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":0.9,"value":450.0,"ownership":{"direct":false,"nature":"By Ault Alpha LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Milton C. Ault, III, is the Manager of Ault Alpha GP LLC (\"Ault GP\") and Ault Capital Management LLC (\"AC Management\").  Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP."}],"balance_after":26032,"source":{"system":"sec-edgar","filing":"0001214659-23-016923","document":"marketforms-63932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465923016923/marketforms-63932.xml","form_type":"4"}},{"id":1699387,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-27T21:30:16.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":0.9242,"value":184.84,"ownership":{"direct":true},"balance_after":166866,"source":{"system":"sec-edgar","filing":"0001214659-23-016923","document":"marketforms-63932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465923016923/marketforms-63932.xml","form_type":"4"}},{"id":1773389,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26692,"kind":"person","name":"Katzoff David J","position":1,"cik":"0001864317","reported_name":"Katzoff David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-26T22:01:28.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":53000,"price":0.1931,"value":10234.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was bought by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $0.1931. The range of purchase prices on the transaction date was $0.19 to $0.1955 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001864317-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864317/000186431723000001/primary_doc.xml","form_type":"4"}},{"id":1876139,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-27T01:30:27.000Z","date":"2023-05-24","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":0.5947,"value":10704.6,"ownership":{"direct":false,"nature":"By Ault Alpha LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Milton C. Ault, III, is the Manager of Ault Alpha GP LLC (\"Ault GP\") and Ault Capital Management LLC (\"AC Management\").  Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP."}],"balance_after":383000,"source":{"system":"sec-edgar","filing":"0001214659-23-007970","document":"marketforms-61643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465923007970/marketforms-61643.xml","form_type":"4"}},{"id":1908491,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26689,"kind":"person","name":"Jackman Stephan","position":1,"cik":"0001864257","reported_name":"Jackman Stephan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-02T20:30:26.000Z","date":"2023-04-28","kind":"purchase","planned":false,"acquired":true,"shares":37000,"price":0.5405,"value":19998.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":45500,"source":{"system":"sec-edgar","filing":"0001214659-23-006373","document":"marketforms-61359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864257/000121465923006373/marketforms-61359.xml","form_type":"4"}},{"id":1940354,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-23T16:30:12.000Z","date":"2023-03-22","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.435,"value":4350.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares were purchased in an individual retirement account owned by Mrs. McGrath's spouse.  Mrs. McGrath disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001214659-23-004146","document":"marketforms-61011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465923004146/marketforms-61011.xml","form_type":"4"}},{"id":1944236,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T20:30:16.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.4298,"value":2149.0,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AA\"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11060001,"source":{"system":"sec-edgar","filing":"0001214659-23-004021","document":"marketforms-60942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465923004021/marketforms-60942.xml","form_type":"4"}},{"id":1944235,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T20:30:16.000Z","date":"2023-03-16","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.5014,"value":2005.6,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5014. The range of purchase prices on the transaction date was $0.5014 to $0.5015 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AA\"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11055001,"source":{"system":"sec-edgar","filing":"0001214659-23-004021","document":"marketforms-60942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465923004021/marketforms-60942.xml","form_type":"4"}},{"id":1986366,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-02-28T21:30:44.000Z","date":"2023-02-24","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options exercised in this transaction were fully vested and exercisable as of the transaction date."}],"balance_after":1500000,"derivative":{"exercise_price":0.004,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001214659-23-003255","document":"marketforms-59668.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465923003255/marketforms-59668.xml","form_type":"4"}},{"id":1986365,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":742,"kind":"person","name":"Horne William B.","position":1,"cik":"0001333268","reported_name":"Horne William B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T21:30:44.000Z","date":"2023-02-24","kind":"exercise","acquired":true,"shares":500000,"price":0.004,"value":2000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001214659-23-003255","document":"marketforms-59668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333268/000121465923003255/marketforms-59668.xml","form_type":"4"}},{"id":2007020,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-18T02:55:20.000Z","date":"2023-02-15","kind":"purchase","acquired":true,"shares":1000,"price":0.5973,"value":597.3,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of Ault Alliance, Inc. (\"AA\"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11051001,"source":{"system":"sec-edgar","filing":"0001214659-23-002742","document":"marketforms-59552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465923002742/marketforms-59552.xml","form_type":"4"}},{"id":2074846,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-29T11:00:12.000Z","date":"2022-12-28","kind":"purchase","acquired":true,"shares":3100,"price":0.5629,"value":1744.99,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5629. The range of purchase prices on the transaction date was $0.5594 to $0.5754 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of BitNile Holdings, Inc. (\"BH\"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11050001,"source":{"system":"sec-edgar","filing":"0001214659-22-015441","document":"marketforms-58000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465922015441/marketforms-58000.xml","form_type":"4"}},{"id":2074845,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-29T11:00:12.000Z","date":"2022-12-27","kind":"purchase","acquired":true,"shares":900,"price":0.591,"value":531.9,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of BitNile Holdings, Inc. (\"BH\"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11046901,"source":{"system":"sec-edgar","filing":"0001214659-22-015441","document":"marketforms-58000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465922015441/marketforms-58000.xml","form_type":"4"}},{"id":2076655,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-23T21:30:18.000Z","date":"2022-12-21","kind":"purchase","acquired":true,"shares":5000,"price":0.8099,"value":4049.5,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of BitNile Holdings, Inc. (\"BH\"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11046001,"source":{"system":"sec-edgar","filing":"0001214659-22-015308","document":"marketforms-57952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465922015308/marketforms-57952.xml","form_type":"4"}},{"id":2079543,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T21:30:27.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":3000,"price":0.8184,"value":2455.2,"ownership":{"direct":false,"nature":"By Ault Lending, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.8184. The range of purchase prices on the transaction date was $0.8154 to $0.8198 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ault Lending, LLC (\"Ault Lending\"), is a wholly-owned subsidiary of BitNile Holdings, Inc. (\"BH\"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending."}],"balance_after":11041001,"source":{"system":"sec-edgar","filing":"0001214659-22-015128","document":"marketforms-57907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465922015128/marketforms-57907.xml","form_type":"4"}},{"id":2079542,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T21:30:27.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":20000,"price":0.8179,"value":16358.0,"ownership":{"direct":false,"nature":"By Ault Alpha LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Milton C. Ault, III, is the Manager of Ault Alpha GP LLC (\"Ault GP\") and Ault Capital Management LLC (\"AC Management\").  Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP."}],"balance_after":365000,"source":{"system":"sec-edgar","filing":"0001214659-22-015128","document":"marketforms-57907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465922015128/marketforms-57907.xml","form_type":"4"}},{"id":2079541,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":718,"kind":"person","name":"AULT MILTON C III","position":1,"cik":"0001212502","reported_name":"AULT MILTON C III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T21:30:27.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":20000,"price":0.898,"value":17960.0,"ownership":{"direct":false,"nature":"By Ault Alpha LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Milton C. Ault, III, is the Manager of Ault Alpha GP LLC (\"Ault GP\") and Ault Capital Management LLC (\"AC Management\").  Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP."}],"balance_after":345000,"source":{"system":"sec-edgar","filing":"0001214659-22-015128","document":"marketforms-57907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212502/000121465922015128/marketforms-57907.xml","form_type":"4"}}],"next_cursor":"2022-12-20T21:30:27.000000Z,2079541"}